Frederick Mutebi Kitaka, is a Ugandan physicist, mathematician, accountant, entrepreneur, and industrialist. He is the executive director of finance of Cipla Quality Chemical Industries Limited (CIPLAQCIL), a Ugandan limited liability company. CIPLAQCIL is the only Sub-Saharan pharmaceutical company that is licensed to manufacture triple therapy antiretroviral medication. He is also a shareholder in the company and sits on its board of directors.[1]
Frederick Mutebi Kitaka | |
|---|---|
| Born | |
| Nationality | Ugandan |
| Citizenship | Uganda |
| Alma mater | St. Mary's College Kisubi (Uganda Certificate of Education) (Uganda Advanced Certificate of Education) Makerere University (Bachelor of Science in mathematics & physics) University of Buckingham (Bachelor of Science in accounting & finance) |
| Occupation(s) | Executive director of finance and economic planning |
| Years active | 1994–present |
| Known for | Enterpreneurship, finance, real estate and pan-African investment |
| Title | Director of finance CIPLAQCIL |
| Board member of | Quality Chemical Industries Limited (QCIL) Namulondo Investments Limited |
| Spouse | Doreen Nassuuna Mutebi (married Oct. 1996 - present) |
| Children | Phillip Nsubuga Mutebi Vanessa Mutebi |
| Parents |
|
His expertise in financial planning and management, economic policy, investment management, and corporate governance has positioned him as a leading figure in his field. Mutebi Kitaka's commitment to societal improvement through his philanthropic efforts further highlights his multifaceted impact on his community and beyond.
Early life and education edit
Mutebi Kitaka was educated at St. Mary's College Kisubi,[2] a distinguished boy's Catholic high school located in Wakiso District in the Central Region of Uganda. He studied mathematics and physics at Makerere University, before pursing a Bachelor of Science degree in Accounting and Finance from the University of Buckingham.[1]
Work history edit
From 1994 until 1997, Mutebi Kitaka worked as the financial controller at Coopers Uganda Limited, a company that later rebranded to MTK Holdings Limited.
In 1997, Mutebi Kitaka co-founded Quality Chemicals Limited, where he served as Chief Finance Officer. The company specialized in distributing human, veterinary, and agrochemical products, marking the beginning of his illustrious career in the pharmaceutical industry.
In 2005, he elevated his entrepreneurial journey by co-founding Cipla Quality Chemical Industries Limited, a pharmaceutical manufacturing plant renowned for producing high-quality WHO pre-qualified treatments for HIV/AIDS, Malaria, and Hepatitis B. Under his leadership, the company achieved a significant milestone with a successful IPO in 2018, valuing it at USD255 million.
Real estate and other ventures edit
Beyond pharmaceuticals, Mutebi Kitaka has made notable strides in real estate development across East Africa. He also plays a vital role in various boards, contributing to the economic development and fostering entrepreneurship in East Africa. He serves as the Board Chairman of Namulondo Investments Limited, an investment arm of the Royal Kingdom of Buganda, and holds board memberships in Legacy Capital and Biashara Capital, among others.
Philanthropy edit
Kitaka's philanthropic efforts are evident in his active participation in the African Leadership Initiative of the Aspen Global Leadership Network, which aims at addressing societal challenges through entrepreneurial leadership.
See also edit
References edit
- ^ a b CQCIL. "Board of Directors: Frederick Mutebi Kitaka - Executive Director & Chief Finance Officer". Cipla Quality Chemical Industries Limited (CQCIL). Retrieved 28 March 2015.
- ^ "Kitaka, the brain behind Africa's first ARVs factory". www.newvision.co.ug. Retrieved 23 May 2020.